The impact of IBD medications on risk of pneumonia and pneumonia-related hospitalisation: a nationwide cohort study of 56 410 IBD patients,Alimentary Pharmacology & Therapeutics

当前位置： X-MOL 学术 › Aliment. Pharm. Ther. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

The impact of IBD medications on risk of pneumonia and pneumonia-related hospitalisation: a nationwide cohort study of 56 410 IBD patients
Alimentary Pharmacology & Therapeutics ( IF 7.6 ) Pub Date : 2021-10-19 , DOI: 10.1111/apt.16610
Nabeel Khan _{1,

2} , Dhruvan Patel ₂ , Chinmay Trivedi ₁ , Tyler Pernes ₁ , Himanshu Kavani _{1,

3} , Dawei Xie ₄ , Yu-Xiao Yang _{1,

2,

5}

Affiliation

There are limited data on the incidence of pneumonia and pneumonia-related hospitalisation in the IBD population, and on any association of IBD medications with such outcomes.

中文翻译：